StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -C$19.50M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-C$19.50M–
FY2024Dec 31, 2024-C$16.84M–

More NervGen Pharma figures

See a number that looks wrong?